Trials / Unknown
UnknownNCT04724577
12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer
Phase I Study on Carbon Ion Radiotherapy in 12 Fractions for Localized Prostate Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Shanghai Proton and Heavy Ion Center · Academic / Other
- Sex
- Male
- Age
- 45 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The arm of this study is to explore the optimal dose of 12 fractions of carbon ion radiotherapy for prostate cancer in our center.
Detailed description
The radiation dose of 51.6GyE in 12 fractions is currently widely used in Japan, and clinical studies of 51.6GyE/12Fx have also been carried out for SBRT. There are some differences in equipment and carbon ion treatment planning system used between Japan and our center. Therefore, we designed this phase I clinical study to explore the optimal dose of 12 fractions of carbon ion radiotherapy for prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | carbon ion radiotherapy | dose escalation radiotherapy with five levels of dose from 54GyE/12Fx to 58.8GyE/12Fx |
Timeline
- Start date
- 2019-12-01
- Primary completion
- 2022-12-01
- Completion
- 2023-06-01
- First posted
- 2021-01-26
- Last updated
- 2021-11-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04724577. Inclusion in this directory is not an endorsement.